Growth Opportunity Newsletter – Healthcare and Life Sciences | A Transformational Growth Journey Powered by the Growth Pipeline Engine

Growth Opportunities in Pharmacovigilance and Safety Testing

From Labor-intensive to Digitally Enabled: The Future of Drug Safety Monitoring

Opportunities in Revenue Cycle Management (RCM) Operations

Growth Webinar: Top 50 Technologies
Robotic-assisted Surgical Devices
Digital Surgery Devices Industry
Global Megatrends for 2026
Emerging Technologies
Discover key opportunities in intelligent imaging, AI-enabled clinical trials, and drug discovery.
Life Sciences
What is the future growth potential of clinical laboratory services, cell and gene therapeutics, and bio-pharma?

  • Capitalize on preventive care models to drive laboratory growth.
  • How can automation enhance operational efficiency?
Read More

  • Leverage growth in CGT by adopting vivo gene therapies.
  • How will gene-editing approvals drive commercialization?
Read More

  • Adopt best practices to navigate policy changes reshaping pharma.
  • What growth opportunities arise in biosimilar production?
Read More

  • Are you prepared to thrive amid the ADC revolution?
  • Assess contract development & manufacturing organizations.
Read More

  • Capture key growth avenues in synthetic biology.
  • What best practices help adopt GenAI to improve outcomes?
Read More

  • Harness AI-driven imaging for precision immunomodulation.
  • Which innovations are driving growth in healthcare?
Read More

Introducing Frost & Sullivan’s Healthcare and Life Sciences LinkedIn Page

Explore key strategic Imperatives, growth opportunity news, innovative business models, competitive benchmarking, best practices, and Transformational Growth Leadership discussions related to the healthcare and life sciences landscape.
Transformational Growth Leadership Program
Explore Executive Perspectives on Business Transformation

Interview with Dr. Yaser Dezhkam

Building Resilient Biopharma Manufacturing: How Kirsch BioPharm Is Redefining Innovation, Sustainability, and Global Scale

Read the Full Interview

Dr. Yaser Dezhkam

Managing Director | Kirsch BioPharm GmbH

Interview with Weena Leck

Building Resilient Biopharma Manufacturing: How Kirsch BioPharm Is Redefining Innovation, Sustainability, and Global Scale

Read the Full Interview

Weena Leck

Managing Director | Kirsch Pharma Asia-Pacific

Interview with Dr. Vasu Rangadass

Reimagining LIMS: How L7 Informatics Is Accelerating the Next Wave of Digital Transformation

Read the Full Interview

Dr. Vasu Rangadass

Founder and Strategy Officer | L7 Informatics

Interview with Vijay Ramanathan

RamSoft’s Transformational Growth Strategy: AI, Cloud, and the Future of Imaging

Read the Full Interview

Vijay Ramanathan

CEO | Ramsoft

Interview with Dr. Chris Chen

Scaling Biologics Innovation: How WuXi Biologics Became a Global CRDMO Partner

Read the Full Interview

Dr. Chris Chen

CEO | WuXi Biologics

Interview with Angel Alberich-Bayarri

From Pixels to Biomarkers: How Quibim Is Redefining the Future of Precision Medicine

Read the Full Interview

Angel Alberich-Bayarri

CEO | Quibim

Interview with Federico Ruiz

Reimagining Patient Engagement: How Puppeteer.ai is Redefining the Digital Front Door with Agentic AI

Read the Full Interview

Federico Ruiz

CEO | Puppeteer.ai

Interview with Dr. Veerapol Khemarangsan

From Biobank to Biopharmaceutical: How MEDEZE Is Building the Future of Regenerative Medicine

Read the Full Interview

Dr. Veerapol Khemarangsan

CEO | MEDEZE

Interview with Prashant Warier

Reimagining Global Healthcare: How Qure.ai is Scaling AI to a Billion Lives

Read the Full Interview

Prashant Warier

Co-founder and CEO | Qure.ai

Interview with William Moss

Democratizing Real-world Evidence: How 3Aware is Empowering MedTech Innovators

Read the Full Interview

William Moss

CEO | 3Aware

Interview with Phillip Stoltzfus

Democratizing Real-world Evidence: How 3Aware is Empowering MedTech Innovators

Read the Full Interview

Phillip Stoltzfus

VP of Marketing & Public Relations | 3Aware

Interview with John Moller

Shaping the Future of Biotech Trials: An Interview with John Moller, CEO of Novotech

Read the Full Interview

John Moller

CEO | Novotech

Interview with Srulik Dvorsky

Transforming Healthcare Affordability: An Exclusive Interview with Srulik Dvorsky, CEO & Co-Founder of TailorMed

Read the Full Interview

Srulik Dvorsky

CEO & Co-founder | TailorMed

Interview with Yvonne Lungershausen

The Future of Biotech CROs: An Exclusive Interview with Yvonne Lungershausen, CEO, Avance Clinical

Read the Full Interview

Yvonne Lungershausen

CEO | Avance Clinical

Kirsch BioPharm MD
Kirsch BioPharm MD APAC
L7 Informatics
RamSoft
WuXi Biologics
Quibim
Puppeteer.ai
MEDEZE
Qure.ai (1)
3Aware CEO
3Aware VP
Novotech
TailorMed
Avance Clinical
Enterprise Wireless Services
How can your organization thrive amidst the transformation of the ever-evolving NG911 and 5G industries?
Healthcare IT
Which growth prospects are emerging due to investments in healthcare IT and developments in the healthcare cloud?
Global Healthcare IT Investment Growth Opportunities
Leverage platform-centric models to drive growth. Align with capital shifts in scalable virtual care platforms and improve provider efficiency & care.
Learn more
Top 10 Strategic Imperatives in the Healthcare Cloud
How is the AI-native cloud transforming healthcare intelligence? What role do interoperable data ecosystems play in care integration?
Learn more
Voice of Customer—Healthcare Cloud User Analysis
Align your strategies to overcome operational complexity. Adopt multicloud architectures and address healthcare cloud adoption challenges.
Learn more

Frost & Sullivan Brand and Demand Solutions

Reach out to our Brand & Demand team for unique solutions to roles like brand marketing, demand generation, events marketing, partner marketing, product marketing, content marketing, field marketing, and account-based marketing within your marketing ecosystem!

Frost & Sullivan Podcasts
Business • Management • 344 episodes
Frost & Sullivan Podcasts
Latest episode
Show notes
Welcome to the Frost & Sullivan Podcast! Here, we empower leaders to accelerate their growth and drive transformative change within their industries. As the growth pipeline company, we provide you with the strategies, tools, and resources needed to thrive in today’s dynamic landscape. Each episode features expert opinions, real-world case studies, and actionable strategies to help you harness emerging technologies, innovative business models, and global megatrends. Our goal is to guide you on a journey of continuous innovation, where you can discover powerful growth opportunities, align your organization’s vision, and achieve best-in-class leadership. From healthcare to technology, energy, and beyond, we will explore industry-specific transformations, new industry dynamics, and collaboration opportunities to shape the future. Join us as we dive deep into the growth strategies that fuel success and help you co-create the future of your industry. Tune in for: • In-depth analysis of the latest industry developments and disruptive technologies • Strategic approaches to accelerate growth and innovation • Best-practice models for achieving transformational success • Conversations with industry growth experts and thought leaders • Opportunities to join the global Growth Council and engage with peers Ready to take your growth journey to the next level? Book a Growth Strategy Session today, and let’s start shaping the future together. Explore new growth opportunities. Drive your transformation. Be the leader of tomorrow. Please tune into our podcasts to gain periodic insights and to know more about our Growth Partnership Services email us at digital@frost.com
How AI, IoT, and Natural Refrigerants Are Transforming the Refrigeration Equipment Industry
6 min
Growth Opportunities in the Global Motor Services Industry
6 min
Competitive Benchmarking of Supply-Side Platforms: Growth and Innovation Strategies for the AdTech Revolution
11 min
Emerging Growth Opportunities in Aeronautical Information Management (AIM)
5 min
More episodes
MedTech
Which medical technologies are pioneering a connected, personalized, and sustainable healthcare ecosystem?
The Future of MedTech Landscape
Adopt regenerative and digital innovations to pioneer personalized healthcare.
Hemodynamic Monitoring Systems
Identify growth gaps impacting the adoption of precision monitoring technologies.
Medical Devices, Surgical Robots, & Medical Imaging
Capitalize on single-port and endovascular robots to transform surgical care.
Growth Webinars
Register Now
Exploring High-growth Investment Opportunities in Europe, 2026: Global Realignments, Economic Momentum, and Sectoral Investment Hotspots
Register Now
Top 50 Technologies for 2026 (16th edition - Asia-Pacific): Technologies Driving Multibillion Dollar Growth Opportunities
Register Now
Top 50 Technologies for 2026 (16th edition - Global): Significant Technologies Driving Multibillion Dollar Growth Opportunities
Register Now
Register now to view the latest on-demand healthcare and life sciences growth webinars.

The Growth Innovation Leadership Council

An unparalleled platform for executives seeking to accelerate their transformational growth journeys.
Digital Content & Cloud
How can your team grow rapidly in the ABM platform, content delivery network, and cloud service industries?
Capitalize on AI-driven go-to-market (GTM) orchestration to drive growth.
Account-based Marketing (ABM)
Harness innovations in edge computing and content delivery networks.
Content Distribution & Infrastructure
How can you benefit from AI-ready, cost-optimized, and modernized cloud solutions?
Cloud Services Ecosystem
Identify and address growth gaps across security and cloud workloads.
Cloud Infrastructure and Platforms
Press Releases & Latest Industry Developments
Patient Access Solutions
Innovaccer Receives Frost & Sullivan’s 2026 United States New Product Innovation Recognition for Excellence in AI-Driven Patient Access Solutions

Frost & Sullivan is pleased to announce that Innovaccer has received the  2026 United States New Product Innovation Recognition in the United States Patient Access Solutions Industry for its outstanding achievements in innovation, strategy execution, and customer impact.



Click here to explore our Best Practices Recognition program that awards companies throughout a range of regional and global industries for their superior leadership and innovation
Digital Pathology - Healthcare Informatics
Philips Receives Frost & Sullivan’s 2025 Global Enabling Technology Leadership Recognition for Excellence in Digital Pathology–Healthcare Informatics

Frost & Sullivan is pleased to announce that Philips has been awarded the 2025 Global Enabling Technology Leadership Recognition in the Digital Pathology–Healthcare Informatics sector for its outstanding achievements in delivering next-generation digital pathology innovation, accelerated workflow modernization, and clinical informatics.



Click here to explore our Best Practices Recognition program that awards companies throughout a range of regional and global industries for their superior leadership and innovation
Exclusive Interview: NEUCA
How NEUCA Is Transforming European Pharmaceutical Supply Chains Through a CDMO-led Model of Flexibility, Efficiency, and Trust

In this Movers & Shakers conversation, Tomasz Nawrocki, Group Contract Manufacturing & Services Director at NEUCA, discusses how NEUCA’s CDMO and services platform is evolving to meet these challenges, by focusing on operational flexibility, targeted manufacturing niches, and deep, long-term customer relationships.


SCOPE Summit 2026
From AI Experimentation to Execution: How Digital Protocols Defined SCOPE Summit 2026

Held from 2–5 February 2026 in Orlando, Florida, SCOPE Summit 2026 marked a decisive turning point for the clinical research ecosystem. What was once discussed as future potential; AI in clinical trials, connected data environments, and patient-centric execution, is now being operationalized at scale.


Cell Therapy
Cell Therapy’s Full-chain Integration and Commercial Acceleration

Cell therapy, arguably the most disruptive frontier in modern biopharmaceuticals, is now seeing its industrial-scale manufacturing and commercial rollout gather unstoppable momentum. Driven by sustained advances in stem-cell and immune-cell mechanistic research, process development, and clinical validation—and under an increasingly mature global regulatory framework—the first wave of innovative products has now gained marketing approval, signaling that the field has established a full—spectrum industrial paradigm spanning discovery, manufacturing, and registration.



Frost & Sullivan Institute

A 501 (c)(3) not-for-profit dedicated to utilizing business practices to address global priorities. We have identified strategic imperatives for transformation and believe that by using a Socratic approach, we can truly accelerate innovation to zero (Zero illiteracy, zero disparity, zero disease, zero poverty, zero degradation, and zero hunger)
Upcoming Frost & Sullivan Events
Contact Center Solutions
Navigate major shifts and optimize growth strategies for the CX and WEM landscapes.
Elevating Customer Experience through Strategic Innovation 
Elevating Customer Experience (CX)
Gain an edge by leveraging the precision CX model to turn contact centers into growth enablers.
Navigating CX in the Retail Industry 2025 to 2027 – Customer Perspectives
Navigating CX in the Retail Industry
Identify key AI-driven capabilities supporting onboarding and self-service in retail customer care.
Frost Radar™: Workforce Engagement Management
Benchmarking WEM Companies
Is your workforce engagement management (WEM) strategy evolving to boost efficiency?
Why CX Leaders Are Betting on Advanced AI Analytics
CX & Advanced AI Analytics
Grow by democratizing CX intelligence and harnessing hyper-personalization needs.

Frost Growth Expert Network

A global network of diverse experts spanning industry, technology, career tracks, geography, strategy, best practices, and human intelligence. Have you leveraged diverse industry experts to drive innovation in your company?
Growth Opportunity Videos
Explore a wide range of Growth Webinars and Growth Podcasts highlighting emerging opportunities in the healthcare and life sciences landscape.
Growth Webinar: The 2026 Healthcare and Life Sciences Playbook
Healthcare & Life Sciences
Viral Vector Manufacturing
Revenue Cycle Management
Global Megatrends
Medical Devices and Imaging
Top 50 Technologies
CDMO Live Europe

CDMO Live Europe

Dates: May 19-21, 2026
Venue: Rotterdam

We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series. CDMO Live connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.

Frost & Sullivan clients receive 20% off registration with code FROST20.

Medical Fair India 2026

Medical Fair India 2026

Dates: 17 – 19 September 2026
Venue: Bombay Exhibition Center, Goregaon (E), Mumbai

Medical Fair India is an international trade fair, exhibition, and conference for hospitals, health centres, and clinics. It serves as a world-class platform for industry engagement, innovation, and collaboration. The show receives strong institutional support from leading industry associations and key healthcare stakeholders, including policymakers, innovators, medical device manufacturers, hospitals, tech start-ups, and researchers.

CDMO Live Americas

CDMO Live Americas

Dates: October 19-21, 2026
Venue: Boston

We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series. CDMO Live connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.

Frost & Sullivan clients receive 20% off registration with code FROST20.

CDMO Live Europe
CDMO Live Americas
Medical-Fair-India-2026

Growth

Let's Talk About Your Project

Examine she brother prudent add day ham. Far stairs now coming bed oppose hunted become his. You zealously departure had procuring suspicion. Books whose front would purse if be do decay. Quitting you way formerly disposed perceive ladyship are.